AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI's impact in ...

Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in ...

That's the top-line finding of the latest financing report from the UK BioIndustry Association (BIA), which reveals that ...

The BioIndustry Association (BIA) has published new data revealing that the UK’s life sciences sector attracted £1.23 billion ...

Recursion Pharmaceuticals RXRX and Relay Therapeutics RLAY are pioneering the use of artificial intelligence (AI) in drug discovery for various indications across different disease areas. They ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials ...

As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech hub of Cambridge.

China has conducted its first clinical trial of brain-computer interface (BCI) technology, allowing a patient with tetraplegia to control electronic devices with their mind. The implant used in ...

Isomorphic Labs is setting up an office in Cambridge, Mass., as it prepares for clinical trials of some of its AI-enabled drug candidates.

Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)’s Institute for Psychedelic ...